Sep 30, 2022 / 02:30PM GMT
Operator
Good afternoon. Welcome to the Astria R&D Day. (Operator Instructions) At this time, I would like to turn the call over to your host, Dr. Jill Milne, Co-Founder and CEO of Astria Therapeutics. Please go ahead, Dr.
Jill C. Milne - Astria Therapeutics, Inc. - Co-Founder, CEO, President & Director
Hello, everyone. I'm Jill Milne, CEO of Astria Therapeutics. We are very glad to have you here with us today at our first Astria R&D Day. I will start today's event by providing an introduction to our company and our vision for how we believe that our lead product candidate STAR-0215 can positively impact the lives of people living with hereditary angioedema or HAE.
I would like to note that during today's event, as mentioned here, we will make forward-looking statements related to our business based on current and future expectations. Actual results may differ from those indicated by these statements as a result of a variety of risks and uncertainties, including those discussed in our most recent Form 10-K and our subsequent SEC filings. Such
Astria Therapeutics Inc R&D Day: Update On STAR-0215 And Its Clinical Development For The Prevention Of HAE Attacks Transcript
Sep 30, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers